NCT00006348 - Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

September 30, 2001

Study Completion Date

September 30, 2001

Conditions

Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesNausea and VomitingPrecancerous ConditionSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG

ondansetron

OTHER

placebo

Trial Locations (12)

55905

Mayo Clinic Cancer Center, Rochester

57709

Rapid City Regional Hospital, Rapid City

58201

Altru Health Systems, Grand Forks

58501

Medcenter One Health System, Bismarck

61801

CCOP - Carle Cancer Center, Urbana

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

85259-5404

CCOP - Scottsdale Oncology Program, Scottsdale

50309-1016

CCOP - Iowa Oncology Research Association, Des Moines

51101-1733

Siouxland Hematology-Oncology, Sioux City

67214-3882

CCOP - Wichita, Wichita

43623-3456

CCOP - Toledo Community Hospital Oncology Program, Toledo

57105-1080

CCOP - Sioux Community Cancer Consortium, Sioux Falls

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER